Joel Scanlon

Joel Scanlon

Digital Specialist and Founder of News-Medical.Net

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Articles from Joel

Santa Fe Gold to Acquire Columbus Silver Corporation

Barrick Gold Makes New Discoveries in Nevada

Copper Mountain Mining Sends First Batch of Concentrate to Japan

Mining Mergers and Acquisitions Expected to Slow Down

Rio Tinto MD Says Carbon Tax Will Hurt, Not Viable

PetroWorth Signs Farm-In Agreement with Pine Petroleum

Minsud Resources Reports Phase I Drilling Results from Chita Valley Property

Cartier Resources Commences Initial Drilling at Diego Gold Project

Viking Minerals Returns High Copper from Dolly Varden Claims

Bard Ventures Proclaims Phase I Initial Exploration Results from Lone Pine Property

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.